Rationalisation of the Differences between APOBEC3G Structures from Crystallography and NMR Studies by Molecular Dynamics Simulations

被引:13
作者
Autore, Flavia [1 ]
Bergeron, Julien R. C. [1 ,2 ]
Malim, Michael H. [2 ]
Fraternali, Franca [1 ]
Huthoff, Hendrik [2 ]
机构
[1] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England
[2] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England
来源
PLOS ONE | 2010年 / 5卷 / 07期
基金
英国医学研究理事会; 英国惠康基金;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE-STRANDED-DNA; CYTIDINE DEAMINATION; CATALYTIC DOMAIN; RETROVIRAL INFECTION; CRYSTAL-STRUCTURE; MODEL STRUCTURE; HIV-1; VIF; PROTEINS; RNA;
D O I
10.1371/journal.pone.0011515
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The human APOBEC3G (A3G) protein is a cellular polynucleotide cytidine deaminase that acts as a host restriction factor of retroviruses, including HIV-1 and various transposable elements. Recently, three NMR and two crystal structures of the catalytic deaminase domain of A3G have been reported, but these are in disagreement over the conformation of a terminal beta-strand, beta 2, as well as the identification of a putative DNA binding site. We here report molecular dynamics simulations with all of the solved A3G catalytic domain structures, taking into account solubility enhancing mutations that were introduced during derivation of three out of the five structures. In the course of these simulations, we observed a general trend towards increased definition of the beta 2 strand for those structures that have a distorted starting conformation of beta 2. Solvent density maps around the protein as calculated from MD simulations indicated that this distortion is dependent on preferential hydration of residues within the beta 2 strand. We also demonstrate that the identification of a pre-defined DNA binding site is prevented by the inherent flexibility of loops that determine access to the deaminase catalytic core. We discuss the implications of our analyses for the as yet unresolved structure of the full-length A3G protein and its biological functions with regard to hypermutation of DNA.
引用
收藏
页数:14
相关论文
共 57 条
[41]   Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts [J].
Mangeat, B ;
Turelli, P ;
Caron, G ;
Friedli, M ;
Perrin, L ;
Trono, D .
NATURE, 2003, 424 (6944) :99-103
[42]   Complementary function of the two catalytic domains of APOBEC3G [J].
Navarro, F ;
Bollman, B ;
Chen, H ;
König, R ;
Yu, Q ;
Chiles, K ;
Landau, NR .
VIROLOGY, 2005, 333 (02) :374-386
[43]   Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity [J].
Newman, ENC ;
Holmes, RK ;
Craig, HM ;
Klein, KC ;
Lingappa, JR ;
Malim, MH ;
Sheehy, AM .
CURRENT BIOLOGY, 2005, 15 (02) :166-170
[44]   Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase [J].
Nowarski, Roni ;
Britan-Rosich, Elena ;
Shiloach, Tamar ;
Kotler, Moshe .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2008, 15 (10) :1059-1066
[45]   AID mutates E-coli suggesting a DNA deamination mechanism for antibody diversification [J].
Petersen-Mahrt, SK ;
Harris, RS ;
Neuberger, MS .
NATURE, 2002, 418 (6893) :99-103
[46]   The APOBEC-2 crystal structure and functional implications for the deaminase AID [J].
Prochnow, Courtney ;
Bransteitter, Ronda ;
Klein, Michael G. ;
Goodman, Myron F. ;
Chen, Xiaojiang S. .
NATURE, 2007, 445 (7126) :447-451
[47]   Crystal Structure of the APOBEC3G Catalytic Domain Reveals Potential Oligomerization Interfaces [J].
Shandilya, Shivender M. D. ;
Nalam, Madhavi N. L. ;
Nalivaika, Ellen A. ;
Gross, Phillip J. ;
Valesano, Johnathan C. ;
Shindo, Keisuke ;
Li, Ming ;
Munson, Mary ;
Royer, William E. ;
Harjes, Elena ;
Kono, Takahide ;
Matsuo, Hiroshi ;
Harris, Reuben S. ;
Somasundaran, Mohan ;
Schiffer, Celia A. .
STRUCTURE, 2010, 18 (01) :28-38
[48]   The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif [J].
Sheehy, AM ;
Gaddis, NC ;
Malim, MH .
NATURE MEDICINE, 2003, 9 (11) :1404-1407
[49]   Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein [J].
Sheehy, AM ;
Gaddis, NC ;
Choi, JD ;
Malim, MH .
NATURE, 2002, 418 (6898) :646-650
[50]   COMPLEMENTATION OF VIF-DEFECTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY PRIMATE, BUT NOT NONPRIMATE, LENTIVIRUS VIF GENES [J].
SIMON, JHM ;
SOUTHERLING, TE ;
PETERSON, JC ;
MEYER, BE ;
MALIM, MH .
JOURNAL OF VIROLOGY, 1995, 69 (07) :4166-4172